thiazolidines has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cross, DAE; Floc'h, N; Martin, MJ; Ménard, L | 1 |
| Cha, PH; Cho, J; Cho, YH; Choi, KY; Han, G; Kim, T; Lee, HY; Lee, J; Lee, SK; Min, DS; Park, J; Shin, WJ; Yang, JS | 1 |
| Jiang, C; Li, F; Li, X; Liu, Y; Su, G; Wu, L; Yan, B; Zhai, S; Zhang, B; Zhang, C; Zhang, Q; Zhang, S; Zhou, H | 1 |
| Chiu, SJ; Hwang, JJ; Keng, PC; Lee, YJ; Sheu, TJ; Tsai, CH | 1 |
| Ji, H; Lai, Y; Li, Y; Sun, Y; Ye, X; Zhang, Y; Zhou, W | 1 |
| Debeir, O; Decaestecker, C; Hayot, C; Kiss, R; Van Damme, M; Van Ham, P | 1 |
| Davis, JJ; Dong, F; Fang, B; Guo, W; Sasaki, J; Teraishi, F; Wu, S; Zhang, L | 1 |
7 other study(ies) available for thiazolidines and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Reactivation of Mutant-EGFR Degradation through Clathrin Inhibition Overcomes Resistance to EGFR Tyrosine Kinase Inhibitors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Clathrin; Drug Resistance, Neoplasm; Endocytosis; ErbB Receptors; Humans; Lung Neoplasms; Lysosomes; Mutation; Protein Kinase Inhibitors; Proteolysis; Signal Transduction; Sulfonamides; Thiazolidines | 2018 |
A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer.
Topics: Animals; beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Lung Neoplasms; MAP Kinase Signaling System; Mice; Protein Kinase Inhibitors; Protein Stability; Proto-Oncogene Proteins p21(ras); ras Proteins; Thiazolidines | 2019 |
Synergistic action by multi-targeting compounds produces a potent compound combination for human NSCLC both in vitro and in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; G2 Phase Cell Cycle Checkpoints; Gene Expression Profiling; Histone Deacetylase Inhibitors; Humans; Lung Neoplasms; Mice; Mice, Nude; Molecular Structure; Molecular Targeted Therapy; Oligonucleotide Array Sequence Analysis; Signal Transduction; Structure-Activity Relationship; Thiazolidines; Time Factors; Tubulin Modulators; Xenograft Model Antitumor Assays | 2014 |
Involvement of a p53-independent and post-transcriptional up-regulation for p21WAF/CIP1 following destabilization of the actin cytoskeleton.
Topics: Actins; Adenocarcinoma; Bone Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cytochalasin D; Cytoskeleton; DNA, Neoplasm; Genes, p53; Humans; Lung Neoplasms; Osteosarcoma; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Neoplasm; Thiazolidines; Ubiquitin | 2009 |
Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Caspase 3; Caspase 8; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; Humans; Immunohistochemistry; Lung Neoplasms; Mice; Reverse Transcriptase Polymerase Chain Reaction; Thiazolidines | 2010 |
Characterization of the activities of actin-affecting drugs on tumor cell migration.
Topics: Actins; Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cytochalasin D; Cytoskeleton; Depsipeptides; Humans; Inhibitory Concentration 50; Lung Neoplasms; Neoplasm Invasiveness; Statistics, Nonparametric; Thiazoles; Thiazolidines | 2006 |
JNK1-dependent antimitotic activity of thiazolidin compounds in human non-small-cell lung and colon cancer cells.
Topics: Aniline Compounds; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle Proteins; Colonic Neoplasms; Enzyme Activation; Humans; Lung Neoplasms; Microtubules; Mitogen-Activated Protein Kinase 8; Mitosis; Spindle Apparatus; Thiazoles; Thiazolidines | 2005 |